Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
nice chunk at .0072 ready for the taking before the holiday weekend
You are completely welcome to have your opinion, but I would like to share an email conversation which I have had with CYCA CEO Gary Campbell:
First of all, when I asked him about the near future, his response on 2/8/2013 was:
'It took a few days longer than expected to finalize the Form 10K Annual Report we filed on Tuesday. Hopefully you had a chance to review it and particularly Business of the Issuer and Plan of Operations which always contain detailed Company information. We generally give this filing a week in the market to deal with the additional information we provide therein. We are very excited about what this year will bring. Thx Gary C
Gary Campbell, CEO'
Then, when I did ask about their statement under 'liquidity and capital resources' on the same day, he replied:
Standard legal boilerplate. Unless you are Apple you have to include that as a risk factor. Nothing to worry about
Sent from my Verizon Wireless BlackBerry
SO, those of you selling at way low prices these days, you are getting scared off by others who just want your cheap shares. Also, if you didn't catch what Gary mentioned in 'Business of Issuer' and 'Plan of Operations', it states:
Business of Issuer
Cytta’s technology called Cytta Connect™ is the world’s first open source Special Purpose Medical Network. Our
unique and proprietary system allows us to connect all forms of Bluetooth enabled monitoring devices (FDA and
Non FDA) seamlessly through an Android Smartphone and deliver the data in real-time to a cloud based data
repository which can easily be customized to our client’s requirements.
The Cytta Connect™ system is a cost effective system that works with any manufacturers’ off the shelf Bluetooth
enabled monitoring device and any Android Smartphone. The Cytta Connect system works seamlessly everywhere
there is cellular service. Cytta Connect is currently implementing systems to monitor, COPD, Asthma, Diabetes,
Hypertension and Obesity as well as several major causes of hospital readmission
Cytta was originally formed in 2006 to be a web based service provider for general contractors. This business was
abandoned and the Company in December 2008 merged with Ophthalmic International, Inc. (“OI”), a Nevada
corporation that manufactured and marketed a medical fixation device with a patented designed suction ring that
treats Open Angle and Pigmentary glaucoma. On May 8, 2009, Cytta entered into an Agreement (the
“Agreement”), pursuant to which the transaction was cancelled. These transactions are more fully described in our
Current Reports on Form 8-K filed with the Securities and Exchange Commission on December 12, 2008, May 12,
2009, and May 20, 2009, respectively.
On June 9, 2009, the Company determined that it wished to stay in the medical products industry and pursued an
opportunity to enter into the remote patient monitoring (RPM) sector. On June 18th, 2009, the Company entered
into a Licensing Agreement with Lifespan, Inc. a Nevada Corporation. Through a series of transactions and
business developments commencing in 2002 Lifespan had acquired the expertise and licenses to manufacture,
distribute and market various technology based internet and telephony based access and computing products and
services, consisting of internet access devices, related software and hardware and a series of medical peripherals
designed and adapted to provide remote patient monitoring (RPM) of home based and remote patients.
Under the terms of the Agreement with Cytta, Lifespan granted the Company the exclusive license to manufacture,
sell, distribute, operate, sub-license and market these internet and telephony access devices, products and services in
the United States. The Company has been utilizing the License to develop a model for the internet and telephony
access devices which can incorporate the numerous technology advances which are currently available and has
determined to utilize android based smartphones and tablets as the connectivity devices. In exchange for the
license, Lifespan has received 120,000,000 shares of the Company’s common stock, plus a license fee equal to one
half of one percent (.5%) of the net revenue derived from the sale and use of their products and services. This
transaction is more fully described in our Current Report on Form 8-K filed with the Securities and Exchange
Commission on June 19, 2009.
On November 10th, 2010, the Company entered into an MVNO Mobile Virtual Network Operator Agreement
(herein “MVNO Agreement”) with Vonify Inc. of Toronto, Canada and Georgetown, Grand Cayman Island, BWI
(herein “Vonify”) and MVNO Mobile Virtual Network Operator Corp (herein “MVNO”) of New Westminster,
Canada (“MVNO Corp.”) a company owned and controlled by Mr. Gary Campbell an Officer and Director and
controlling shareholder of Cytta for a license to provide all the “Services” of the Vonify Network to third parties, in
the medical marketplace in the USA as a Special Purpose Medical Network. Cytta may only resell Services to third
parties who are also End Users and such third parties may not further resell the Services. Cytta is expressly
permitted to use and develop their own applications and programing for the phones and may develop and utilize
applications which require modification of the “native” or “core” programing of the Smartphones provided it does
not have a deleterious effect upon the Network.
The Vonify Network includes those integrated mobile switching facilities, servers, cell sites, telecom and internet
connections, billing systems, validation systems, gateways, landline switches and other related facilities used to
provide the Services. Vonify operates the network utilizing the C & F Block Spectrum Licenses and associated
roaming agreements and all the land, towers and antennas along with the associated network agreements.
Pursuant to Cytta’s MVNO agreement with Vonify, the Services to be marketed by Cytta are defined as wireless
telecommunications services for the Global System for Mobile (GSM) communications. The Company has
finalized the testing of the Vonify network in the US utilizing Vonify SIM cards installed on numerous brands of
android smartphones and tablets deployed in various parts of the US. After comprehensive testing, the Cytta
network was found to be fully functional and compliant in regards to voice, data and SMS connectivity. The
network is suitable in all aspects for utilization by Cytta for the movement of medical information gathered from
Bluetooth enabled remote medical monitoring devices. The Cytta Medical smartphones and tablets are also fully
functional voice, data and SMS cell phones.
In exchange for the MVNO Agreement, Cytta issued 250,000,000 shares of the Company’s common stock to Vonify
Inc. This transaction resulted in Vonify Inc. becoming a greater than 10% shareholder of the Company at the time.
Mr. Michael Scott, a Director of the Company, is the controlling shareholder of Vonify Inc. This transaction is more
fully described in our Current Report on Form 8-K filed with the Securities and Exchange Commission on
November 29, 2010.
In an effort to respond to data security concerns related to the transmission of information through a mobile
communications network, on June 24th, 2011, the Company entered into a Joint Venture and Value Added Reseller
Agreement and a final Exclusive License Agreement on August 18th, 2011 (herein the “Agreement”) with Promia,
Inc. of San Francisco, CA (herein “Promia”) to exclusively market on a worldwide basis Promia’s software and
hardware development services and technologies. This transaction is more fully described in our Current Report on
Form 8-K filed with the Securities and Exchange Commission on June 30, 2011.
On January 25th, 2012, the Company’s Board ratified an executed Wireless Data Machine to Machine (M2M)
Communications Agreement with ATT Mobility II, LLC on behalf of its affiliates AT&T or AT&T Mobility (herein
AT&T) pursuant to the terms of which Cytta agrees to purchase from AT&T and AT&T agrees to sell to Cytta
wireless service for use in machine to machine communications on AT&T’s Wireless Data Network. Through
AT&T, Cytta can offer a nationwide Data GSM/GPRS footprint across 100 percent of the AT&T service area. GSM
also provides global compatibility resulting in more international roaming potential. Cytta has currently activated its
first AT&T SIMs through its VPN and is evaluating their market potential. Additional setup, activation and details
are currently being explored between the parties. This transaction is more fully described in our Current Report on
Form 8-K filed with the Securities and Exchange Commission on January 31st, 2012.
Since the acquisition of the Lifespan technology, and the rights to utilize the Vonify Wireless Network through the
Vonify MVNO Agreement, and the AT&T Data MVNO agreement, and the Agreements with the medical device
manufacturers, the Company has now completed the development of a remote medical monitoring model or remote
patient monitoring (RPM) system designed to deliver seamless, near real-time, medical data transmission from home
to Insurer/Provider. The Company’s system seamlessly collects the data generated by the portable or home based
medical monitoring devices (such as blood pressure, scale, blood glucose, pulse oxygen etc.), utilizing Bluetooth
connectivity. This medical data is sent via Bluetooth from the medical device to the Company’s Medical
Smartphone, which is also located in the home and/or held by the patient.
The Company’s Medical Smartphone, contains proprietary device resident or “native” programming, consisting of a
“Firmware Client” or “Super App” developed by Connected Health Pte. Ltd. in conjunction with the Cytta Special
Purpose Network and which is licensed to Cytta pursuant to the July 14
th
, 2011 License Agreement. This
application for the phones is designed to automatically receive Bluetooth data and perform autonomous control and
connectivity functions utilizing the voice, data and SMS capability of the Smartphone or tablet. Connected Health is
a wireless health innovator committed to developing health monitoring connectivity solutions which when installed
on the Cytta Medical Smartphone, automatically receives the medical data and utilizes the Company’s wireless
telecommunication services, to transmit the data through the cellular network to Cytta’s proprietary online or Cloud
based Cytta Data repository Dashboard called the ‘Instant EMR
TM’
.
From the Online or Cloud based Cytta Data repository Dashboard or ‘Instant EMR
TM
’ the data can be utilized as
part of the electronic medical monitoring systems (EMR’s) of the major Medical Groups (such as Insurance
Companies, Disease Management Companies, Health Delivery Organizations, Health Plans, Home Health Agencies,
Managed Care Organizations, Medical Groups and IPAs) who have placed the systems in the homes of their clients
requiring remote patient monitoring. These Medical Groups contract with Cytta and are responsible for installing,
monitoring and financing the system in the homes of their clients who require monitoring.
The Company has currently entered into agreements with respected medical device manufacturers A&D Medical,
Nonin Medical, ForaCare, and Entra Health, which have allowed Cytta to design our ecosystem to incorporate their
double FDA approved medical monitoring devices to for measurement of Blood Pressure, Glucose Values, Weight,
Temperature, Pulse, and Oxygen Saturation. The Company is now capable of adding any Bluetooth remote
monitoring device to the Cytta Connect ecosystem whether FDA approved or Non FDA approved and is currently
working to add PT/INR, ECG Rhythms, Respiration, and a personal emergency response system (PERS) into the
Cytta Ecosystem.
The Company and its licensing partner Connected Health Pte. Ltd. have now completed the development of the
proprietary Firmware Client and have installed the technology on several Nexus One, HTC My Touch, HTC
Wildfire, HTC Sense, Sony Xperia android smartphones as well as with the Samsung and HTC tablets. The testing
and integration of the combination Smartphone/tablets and Firmware Client, which has collectively been described
as the Cytta Medical Smartphone or the Cytta Medical Tablet, with the double FDA blood pressure, weight scale,
pulse/oximetry and blood glucose devices, has been completed and are all functioning seamlessly. The Company
has completed the development of the relational data base and the GUI developed therefrom consisting of ‘Online
Data Presentation Screens” Dashboard or ‘Instant EMR
TM
’ to represent the data captured by the system for its
clients.
The Company began its first trial installations of the complete Cytta Ecosystems in September 2011 in the US, with
two Medical Group clients wishing to utilize and or participate in the Company’s “medical monitoring ecosystem’.
In March 2012 the Company commenced its first major installation and product evaluation with a major medical
Insurance Co/Payor. The Company also delivered its second round of orders to its first two medical group clients
and has received notice of upcoming further installations.
Upon successful conclusion of the Insurance co/Payor Pilot Program evaluation, the Company planned to begin full
deployment of its systems and commence operations as a Medical Health Service Provider (MHSP). In November
2012 the Company received the 6 Month Pilot Program Whitepaper dated September 30, 2012 independently
prepared by the major medical Insurance Co/Payor with whom the Pilot program was conducted. The conclusions
of their Independent Whitepaper stated,
“This trial demonstrated the ability to significantly reduce costs for high risk patients through use of the
CYTTA Connect Ecosystem. The trial demonstrated the ability to quickly achieve cost savings, decrease
resource utilization, improve care coordination, and increase adherence to evidence based guidelines.
Adherence to evidence based guidelines is increasingly important as CMS 5 STAR ratings garner
importance.
Care costs were reduced on average by $11,078 [or $1,846 per member per month] for each trial
participant. This trial did not specifically address long term cost of care. However, these patients were
selected for the inabilities of the existing healthcare system and care coordination programs to cost
effectively address their short or long term healthcare needs. One trial participant noted he realized more
value and benefit in 2 months of trial participation compared to his previous 17 months of participation in
the best available care coordination services. A quite handsome return on investment is present if the care
coordination system is priced at less than $2,000 per year.
This trial also demonstrated that home biometric monitoring using the CYTTA Connect Ecosystem can be
easily introduced, dispensed and utilized in the home setting. Care team training was easily completed.
CYTTA Connect was easy for patients and care coordinators to learn and effectively use. Technical
troubleshooting was prompt and effective.
Improved patient engagement and ability to self-manage care will become increasingly important and
require new resource allocation because CMS will soon require Stage II Readiness participation. Through
repeated collection and review of biometric data patients learn how to titrate medications and adjust
behaviors to achieve target goals which is a cornerstone of CMS 5 STAR performance and CMS Stage II
Readiness. Patients and the care coordination team are prompted by alerts to evaluate and to intervene in
real time. This produces a patient who is more engaged and prospectively aware of how they must
modify behaviors and medications to meet target metrics through self-management. Additionally,
improved achievement of target metrics produces significant provider and care team satisfaction. Efforts
of both become both more effective and more efficient.
Effective use of the CYTTA Connect Ecosystem requires the managing physicians to develop and
communicate care plans and standing orders to adjust medications to achieve target goal. Too often the
goals of care and associated care plans including medication administration are poorly communicated or
not present. Patients travel through various sites of service and levels of care without a clear
understanding of the expected behaviors and medication usage to be executed in the home setting.
CYTTA Connect in conjunction with care coordination resolves this deficit and allows for care plan and
medication revision as the patient disease processes change in the home environment. Through repeated
measurement and with focused care coordination the patient learns how to better manage their health care
needs. This produces a patient who is more engaged and prospectively aware of how they must modify
behaviors and medications to meet target metrics. This also produces a more satisfied patient, physician,
and care coordination team.
This trial discovered patients view CYTTA Connect and remote telemonitoring as a special benefit to
patients who are encouraged to retain their relationship with Heritage to continue to access and build their
personal health database. Patients develop a special relationship with their care coordination team. The
patients viewed CYTTA Connect and care coordination activities as a value rather than an intrusion
because information and advice generated by the trial were specific to the patient and time sensitive.
This trial enabled physicians and care coordinators to more effectively manage a larger number of
patients. Current care coordination ratios can be expanded by 20% using biometric remote telemonitoring
through reduced telephone tag and elimination of unfocused, subjective, generic discussions with patients.
Instead specific biometric data, medication usage, review of the active care plan, and comparison to
target metrics produces a focused discussion. Patients and care coordinators are taught through rapid
cycle improvement to Plan, Do, Study, and ACT. Barriers to successful self-management are identified
and addressed. Patients now learn how to revise and update their care management in the home setting
rather than a physician office, emergency or hospital room followed by an attempt to translate and
implement the care plan in their home setting upon discharge. Patient contacts have become value
oriented with immediate return on investment to the care coordinators and patient.”
As can be seen from the above conclusion, the Company’s integrated and completely autonomous system provides
numerous advantages over current systems, as well as a pricing structure designed to generate a positive return on
investment (ROI) for the Medical Groups utilizing the system. To this end the Company is currently demonstrating
and actively marketing the Cytta Connect system to numerous Medical Group clients wishing to utilize and or
participate in the Company’s “medical monitoring ecosystem”.
Cytta currently has limited operating costs and expenses at the present time due to our relatively new business
activities. However we anticipate significantly increasing our activities as a result of the first sales of our systems
and the installation thereof. We have entered into certain management and consulting contracts with our senior
Officers and non-affiliated consultants who will be providing business services to the Company in the health care
arena. Additionally, we will be required to raise significant capital over the next twelve months, in connection with
our operations resulting from our marketing Agreements. We have engaged in significant product research and
development over the past year while the technology and system was being developed. The Company’s business
may cause us to engage in further research and development in the foreseeable future. We have no present plans to
purchase or sell any plant or significant equipment although we will have to acquire some equipment related to the
marketing Agreements. We also have immediate plans to add employees and we will continue to do so in the future
as a result of the operations related to the marketing of our systems.
Plan of Operation
Cytta has for several years been designing and building an ecosystem that would allow any Bluetooth device to
automatically send its data to our specially provisioned Android SmartPhone and then instantly pass that data unto a
cloud based Electronic Medical Record which is automatically populated with the client’s readings and information.
The goal of the Cytta Connect system was to allow patients, their caregiver or medical providers to review and
monitor their progress remotely on an ongoing basis.
On June 18th, 2009, the Company entered into a Licensing Agreement with Lifespan, Inc. Through a series of
transactions and business developments commencing in 2002, Lifespan had acquired the expertise and licenses to
manufacture, distribute and market various technology-based internet access and computing products and services,
consisting of internet access devices, related software and hardware and a series of medical peripherals designed and
adapted to provide remote non-diagnostic monitoring of home based and remote patients. Under the terms of the
Agreement with Cytta, Lifespan granted the Company the exclusive license to manufacture, sell, distribute, operate,
sub-license and market these internet access devices, products and services in the United States. The Company
plans to utilize the License to develop a model for the internet access devices which can incorporate the numerous
technology advances which are currently available and is currently pursuing this avenue
On November 10
th
, 2010, the Company entered into an MVNO Mobile Virtual Network Operator Agreement
(herein “MVNO Agreement”) with Vonify Inc. of Toronto, Canada and Georgetown, Grand Cayman Island, BWI
(herein “Vonify”) and MVNO Mobile Virtual Network Operator Corp (herein “MVNO”) of New Westminster,
Canada for a license to provide all the “Services” of the Vonify Network to third parties, in the medical marketplace
in the USA. The Vonify Network includes those integrated mobile switching facilities, servers, cell sites, telecom
and internet connections, billing systems, validation systems, gateways, landline switches and other related facilities
used to provide the Services. The Services to be marketed by Cytta are defined as wireless telecommunications
services for the Global System for Mobile (GSM) communications.
Since the acquisition of the Lifespan Technology, and the MVNO Agreement, the Company has a remote medical
monitoring model designed to deliver seamless, near real-time, medical data transmission, through Bluetooth
connectivity, utilizing the Company’s wireless telecommunication services, to major medical payor/providers back
end electronic medical monitoring systems (EMR’s) with a pricing structure sufficient to generate a positive return
on investment (ROI) for the clients.
The Company and its licensing partner have now completed the development of the proprietary Firmware Client and
have installed the technology on several Nexus One, HTC My Touch, HTC Wildfire, HTC Sense, Sony Xperia
android smartphones as well as with the Samsung and HTC tablets. The testing and integration of the combination
Smartphone/tablets and Firmware Client, which has collectively been described as the Cytta Medical Smartphone or
the Cytta Medical Tablet, with the blood pressure, weight scale, pulse/oximetry and blood glucose devices has been
completed and are all functioning seamlessly. The Company has completed the development of the ‘Online Data
Presentation Screens” Dashboard or ‘Instant EMRTM’ to represent the data captured by the system for its clients.
The Company began its first installations of the complete Cytta Ecosystems in September 2011 in the US, with two
Medical Group clients wishing to utilize and or participate in the Company’s “medical monitoring ecosystem’. In
March 2012 the Company commenced its first major installation and product evaluation with a major medical
Insurance Co/Payor. The Company also delivered its second round of orders to its first two medical group clients
and has received notice of upcoming further installations.
Upon conclusion of the Insurance co/Payor Pilot Program evaluation, the Company will begin full deployment of its
systems and commence operations as a Medical Health Service Provider (MHSP). In November 2012 the Company
received the 6 Month Pilot Program Whitepaper dated September 30, 2012 independently prepared by the major
medical Insurance Co/Payor with whom the Pilot program was conducted. To this end the Company is currently in
discussions with potential partners and/or clients wishing to utilize and or participate in the model or the
‘Company’s ‘medical monitoring ecosystem’.
Cytta currently has minimal operating costs and expenses at the present time due to our relatively new business
activities. However we anticipate significantly increasing our activities as a result of the first sales of our systems
and the installation thereof. We have entered into certain management and consulting contracts with our senior
Officers and non-affiliated consultants who will be providing business services to the Company in the health care
arena. Additionally, we will be required to raise significant capital over the next twelve months, in connection with
our operations resulting from our marketing Agreements.
We have engaged in significant product research and development over the past year while the technology and
system was being developed. The Company’s business may cause us to engage in further research and development
in the foreseeable future. We have no present plans to purchase or sell any plant or significant equipment although
we will have to acquire some equipment related to the marketing Agreements. We also have immediate plans to add
employees and we will continue to do so in the future as a result of the operations related to the marketing of our
systems.
This is the ground floor for CYCA - sales are starting and they will surely continue. GLTA
Hi Mr Derf.
Very interesting indeed that you put in the exact words from the 10K which you would like. The entire paragraph reads:
Liquidity and Capital Resources
Our cash and cash equivalents balance as of September 30, 2012 was $36,080.
We currently have three clients utilizing our systems and are fully operational. We currently have many potential clients evaluating systems.
We do not have sufficient funds on hand to pursue our business objectives for the near future or to commence operations without seeking additional funding. We currently do not have a specific plan of how we will obtain such funding.
AND THEN LATER:
We believe that we will be able to raise the required funds for operations and to
achieve our business plan.
AND THEN UNDER PLAN OF OPERATION:
Upon conclusion of the Insurance co/Payor Pilot Program evaluation, the Company will begin full deployment of its systems and commence operations as a Medical Health Service Provider (MHSP). In November 2012 the Company
received the 6 Month Pilot Program Whitepaper dated September 30, 2012 independently prepared by the major
medical Insurance Co/Payor with whom the Pilot program was conducted. To this end the Company is currently in
discussions with potential partners and/or clients wishing to utilize and or participate in the model or the
‘Company’s ‘medical monitoring ecosystem’.
Cytta currently has minimal operating costs and expenses at the present time due to our relatively new business
activities. However we anticipate significantly increasing our activities as a result of the first sales of our systems
and the installation thereof. We have entered into certain management and consulting contracts with our senior
Officers and non-affiliated consultants who will be providing business services to the Company in the health care
arena. Additionally, we will be required to raise significant capital over the next twelve months, in connection with
our operations resulting from our marketing Agreements.
We have engaged in significant product research and development over the past year while the technology and
system was being developed. The Company’s business may cause us to engage in further research and development
in the foreseeable future. We have no present plans to purchase or sell any plant or significant equipment although
we will have to acquire some equipment related to the marketing Agreements. We also have immediate plans to add
employees and we will continue to do so in the future as a result of the operations related to the marketing of our
systems.
Ditka you are very amusing sir!
Uh oh ask is down to .48 time to get really scared now guys.
Very interested to see if these guys can prove themselves in any capacity.
Sending many blessings to this company as well as the one which they will have the strategic alliance or acquisition
quiet before the storm?
.001 will be so cheap in the future ha
Give it time.. this thing bounces back up to .0014+ pretty easily and looks like the company is working on something
News seems to be coming soon..
DBMM Great time to give us some news! Lets hear it guys!
Could be good. Reverse split with name change and new company development could be real big for the long run. Right now we have nothing going and the market cap is 225K! Imagine everything going on with Steve B making this into a 5M market cap,,, JMO :P
hey mark so do you see this sp steadily increasing over this upcoming year? do you think the company has what it takes?
what birdie!? spill the beans mark!
just shareholder relaying an email. owning shares means u own part of the company right?!
RTGVENTURES.COM goes straight to DBMM - obviously the change is happening. anyone who wants out i have a nice bid at .0005 please fill me ill have it up all day thank you.
who is even selling .001 .. so low what is the point.. gonna miss out.
.001 going to be really cheap soon seriously..
From Gary Campbell our President sent to me five days ago:::
Jonathan:
Thank you for taking the time to send us an email, we really appreciate the feedback. As you can probably guess, we have been overwhelmed by responses to our Pilot program Whitepaper and our meetings at CES. As a small Company, dealing with some of the biggest names in the Industry is very exciting. The revolutionary nature of our solution certainly seems to be popular. We are actively developing the implementation and technical contracts to begin full scale deployment. You will see several interesting developments over the next few weeks. After our two year development quiet period we are now ready to make some noise! Thank you for becoming a shareholder and please feel free to contact me with any thoughts, ideas or questions you may have. Thx Gary C
any thought to what price the name change will take this to?
Who Wants To Prove this Wrong - http://www.hotstocked.com/article/43002/nanotech-entertainment-inc-pink-ntek-spikes.html
Pleasantly surprised! Do you think this will make it back to my initial investment at .01 just a few months ago?
I'll be surprised if this goes over .0008 ever again
No revenues, nothing going for this company whatsoever.
Let's get back to that 52 week high!
news coming or what?
No, just a large supply of impatient people unloading at discount for us :) Lets go Paul!
Hey guys - I wrote a message to the contact email address and actually received a response from Paul. I simply asked what the next steps were with us moving forward. This was his response:
"As you know, divulging any information that is not public info to anyone out of normal PR channels would be considered insider knowledge and could get you, me, and the company in trouble. I can tell you that we’re working on many more acquisitions and as they come closer to fruition, I will issue pr’s through the normal channels. We’re working hard to build the company and make MCIC a multi-faceted company with a bright future.
All the best,
Paul Lisenby"
I'm thinking the two current acquisitions were nothing compared to what is being worked on. The company still lists that the focus is in the medical field. Looks like those of us with patience will be rewarded.
Obviously this will fly when news with substance hits... No volume here... When it comes, watch out!
Only noobs selling this low
I'd like to know what you're thinking about this stock right now since this post...
MCIC $$$
#13 on Breakout Boards!!!
what price will this open at?
this things been bleeding down a bit.. what are the thoughts about the future? supposedly news is coming soon!
XMDC $$ NAME CHANGE TOMORROW PLUS 25% SHARE CONVERSION $$$
News coming?
So what does this news mean to you guys??
54's still look quite nice... May be cheapest possible soon...
so that would be the rossomove account right?
weve got some early morning volume coming in!
Goin up! Get em while you can!!!